A framework to guide dose & regimen strategy for clinical drug development
Abstract Optimizing new drug therapies remains a challenge for clinical development, despite the use of ever more sophisticated quantitative methodologies. Although conceptually simple, the idea of finding the right treatment at the right dose for the right patient to ensure an appropriate balance o...
Saved in:
Main Authors: | Oliver Sander, Baldur Magnusson, Inga Ludwig, Astrid Jullion, Christophe Meille, Daniel Lorand, Björn Bornkamp, Markus Hinder, Steven J. Kovacs, Michael Looby |
---|---|
Format: | article |
Language: | EN |
Published: |
Wiley
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/15d1549b9b844cf58ce62297612b8cf4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A framework for economic evaluation of therapeutic drug monitoring—guided dosing in oncology
by: Daniel Erku, et al.
Published: (2021) -
Evaluation framework to guide implementation of AI systems into healthcare settings
by: Enrico Coiera, et al.
Published: (2021) -
Optimization of Initial Dose Regimen for Sirolimus in Pediatric Patients With Lymphangioma
by: Xiao Chen, et al.
Published: (2021) -
Computed tomography-guided core needle biopsy for lung nodules: low-dose versus standard-dose protocols
by: Yi-Yang Huang, et al.
Published: (2021) -
Regimen simplification and medication adherence: Fixed-dose versus loose-dose combination therapy for type 2 diabetes.
by: Anna-Katharina Böhm, et al.
Published: (2021)